Eli Lilly (NYSE:LLY) and Samsung Biologics have agreed to launch a Gateway Labs partnership in Korea. The collaboration will create a new facility offering lab space, operational support, and access ...

NVIDIA (NVDA) and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery. The co-innovation lab ...

Nvidia Corp (NASDAQ: NVDA) and Eli Lilly and Co (NYSE: LLY) are launching a lab designed to apply advanced artificial intelligence to drug development. The collaboration will combine Lilly's expertise ...

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced a collaboration agreement with Eli Lilly and Company (Lilly) to establish a Lilly ...

South Korean contract development and manufacturing organization (CDMO) Samsung Biologics has announced a collaboration agreement with US pharma major Eli Lilly to establish a Lilly Gateway Labs (LGL) ...

Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.

Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...

On the surface, the two companies don't seem as if they'd have much in common. Both benefit from advancing medical technology using AI, however. 10 stocks we like better than Nvidia › In a corporate ...

Eli Lilly and Nvidia will launch a co-innovation AI lab to accelerate drug discovery. The companies will jointly invest up to $1 billion over five years to support the lab, which is based in the Bay ...